Cited by 35Sleep and related disordersTreatment of Major DepressionCircadian rhythm and melatonin

The DOI matches its Crossref record.

Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: Dose‐finding study with no concomitant use of hypnotic agent

Open access

Abstract

This was the first dose‐finding study of trazodone that was designed to be free of the concomitant use of hypnotics, in which the drug was administered in a single dose for sleep disorders combined with a depressive state. As a result, trazodone at the dosage of 50–100 mg/day improved sleep disorders, particularly at the 100 mg/day dosage. It was confirmed that trazodone improved sleep disorders combined with a depressive state when it was administered in a single dose before bedtime with no concomitant hypnotics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1440-1819.1999.00532.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sleep scores on HAMD were significantly better improved for trazodone (50-100mg) than placebo, although the effect was better in lower doses.

    “(Mashiko et al., 1999) found that sleep scores on HAMD were significantly better improved for trazodone (50-100mg) than placebo, although the effect was better in lower doses.”

    From Antidepressants and their effect on sleep (2005) · cites this paper as Mashiko et al., 1999

    The Methods describe three trazodone dose groups (50, 75, and 100 mg/day), with no placebo group. The Discussion says 100 mg/day was most effective for sleep disorders, contrary to the claim that lower doses worked better. The Results report improvement in HRSD sleep items but do not establish a comparison with placebo. (LLM, conf=0.90)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 2

  1. 10.1007/BF00432013 · DOI
  2. 10.1176/ajp.151.7.1069 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Mashiko, H., Niwa, S., Kumashiro, H., Kaneko, Y., Suzuki, S., Numata, Y., Horikoshi, R., & Watanabe, Y.
Affiliations
  • Fukushima Medical University (JP)
  • Shirakawa Kosei General Hospital (JP)
  • Fukushima Red Cross Hospital (JP)
  • Fukuchiyama City Hospital (JP)
Corresponding author
Mashiko, Hirobumi
Venue
Psychiatry and Clinical Neurosciences
Publisher
Wiley
Published
1999-04
Volume
53
Issue
2
Pages
193-194
ISSN
  • 1323-1316 (ISSN-L)
  • 1440-1819
OpenAlex
W1995128400
Cited by
35
References
0
Citations by year
2026: 1 · 2025: 1 · 2022: 1 · 2020: 1 · 2018: 5 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 3
FWCI
1.18
Type
journal article
Language
en
Open access
Locations
  • Psychiatry and Clinical Neurosciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
Keywords
trazodone, sleep disorders, depression, insomnia, dose-finding, single-dose administration, bedtime dosing
MeSH terms
Adult, Depressive Disorder, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Personality Inventory, Trazodone, Treatment Outcome, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review